The invention provides for the use of a botulinum toxin to treat cerebral palsy in juvenile patients by transdermal administration of the botulinum toxin. The juvenile patients are preferably juveniles of up to 6 years in age.

 
Web www.patentalert.com

< Use of colostrinin, constituent peptides thereof, and analogs thereof, as oxidative stress regulators

< Altered human interleukin-1 convertase (ICE), NEDD-2, and C. elegans ced-3 polypeptides and uses therefor

> Composition and method for treating hair containing a cationic ampholytic polymer and an anionic benefit agent

> Composition and method for treatment of neoplastic diseases associated with elevated matrix metalloproteinase activities using catechin compounds
~ 00205